Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A4H4R9
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 5 |
GO:0005488 | binding | 1 | 5 |
GO:0016491 | oxidoreductase activity | 2 | 5 |
GO:0043167 | ion binding | 2 | 5 |
GO:0043169 | cation binding | 3 | 5 |
GO:0046872 | metal ion binding | 4 | 5 |
GO:0051213 | dioxygenase activity | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 8 | 12 | PF00656 | 0.654 |
CLV_NRD_NRD_1 | 234 | 236 | PF00675 | 0.444 |
CLV_NRD_NRD_1 | 306 | 308 | PF00675 | 0.694 |
CLV_PCSK_KEX2_1 | 233 | 235 | PF00082 | 0.439 |
CLV_PCSK_KEX2_1 | 306 | 308 | PF00082 | 0.705 |
CLV_PCSK_PC1ET2_1 | 306 | 308 | PF00082 | 0.741 |
CLV_PCSK_SKI1_1 | 178 | 182 | PF00082 | 0.404 |
CLV_PCSK_SKI1_1 | 303 | 307 | PF00082 | 0.746 |
DOC_CKS1_1 | 218 | 223 | PF01111 | 0.476 |
DOC_CYCLIN_RxL_1 | 175 | 185 | PF00134 | 0.393 |
DOC_MAPK_FxFP_2 | 191 | 194 | PF00069 | 0.395 |
DOC_MAPK_MEF2A_6 | 165 | 174 | PF00069 | 0.376 |
DOC_PP1_RVXF_1 | 176 | 183 | PF00149 | 0.374 |
DOC_PP1_SILK_1 | 57 | 62 | PF00149 | 0.501 |
DOC_PP4_FxxP_1 | 110 | 113 | PF00568 | 0.465 |
DOC_PP4_FxxP_1 | 191 | 194 | PF00568 | 0.395 |
DOC_SPAK_OSR1_1 | 225 | 229 | PF12202 | 0.387 |
DOC_USP7_MATH_1 | 13 | 17 | PF00917 | 0.466 |
DOC_USP7_MATH_1 | 176 | 180 | PF00917 | 0.411 |
DOC_USP7_MATH_1 | 287 | 291 | PF00917 | 0.707 |
DOC_WW_Pin1_4 | 217 | 222 | PF00397 | 0.477 |
LIG_14-3-3_CanoR_1 | 233 | 238 | PF00244 | 0.455 |
LIG_BRCT_BRCA1_1 | 116 | 120 | PF00533 | 0.390 |
LIG_BRCT_BRCA1_1 | 178 | 182 | PF00533 | 0.404 |
LIG_deltaCOP1_diTrp_1 | 103 | 110 | PF00928 | 0.478 |
LIG_FHA_1 | 167 | 173 | PF00498 | 0.365 |
LIG_FHA_1 | 175 | 181 | PF00498 | 0.374 |
LIG_FHA_1 | 202 | 208 | PF00498 | 0.378 |
LIG_FHA_1 | 210 | 216 | PF00498 | 0.405 |
LIG_FHA_1 | 297 | 303 | PF00498 | 0.528 |
LIG_FHA_2 | 117 | 123 | PF00498 | 0.463 |
LIG_FHA_2 | 234 | 240 | PF00498 | 0.498 |
LIG_FHA_2 | 257 | 263 | PF00498 | 0.524 |
LIG_FHA_2 | 287 | 293 | PF00498 | 0.736 |
LIG_FHA_2 | 6 | 12 | PF00498 | 0.664 |
LIG_LIR_Apic_2 | 190 | 194 | PF02991 | 0.525 |
LIG_LIR_Gen_1 | 117 | 128 | PF02991 | 0.371 |
LIG_LIR_Gen_1 | 223 | 230 | PF02991 | 0.399 |
LIG_LIR_Gen_1 | 28 | 37 | PF02991 | 0.335 |
LIG_LIR_Gen_1 | 54 | 64 | PF02991 | 0.466 |
LIG_LIR_Nem_3 | 117 | 123 | PF02991 | 0.378 |
LIG_LIR_Nem_3 | 129 | 133 | PF02991 | 0.353 |
LIG_LIR_Nem_3 | 223 | 229 | PF02991 | 0.401 |
LIG_LIR_Nem_3 | 28 | 32 | PF02991 | 0.537 |
LIG_LIR_Nem_3 | 54 | 59 | PF02991 | 0.406 |
LIG_SH2_CRK | 80 | 84 | PF00017 | 0.428 |
LIG_SH2_STAP1 | 136 | 140 | PF00017 | 0.386 |
LIG_SH2_STAP1 | 298 | 302 | PF00017 | 0.509 |
LIG_SH2_STAT5 | 130 | 133 | PF00017 | 0.322 |
LIG_SH2_STAT5 | 298 | 301 | PF00017 | 0.509 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.364 |
LIG_TRAF2_1 | 290 | 293 | PF00917 | 0.523 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.476 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.451 |
MOD_CK2_1 | 233 | 239 | PF00069 | 0.470 |
MOD_CK2_1 | 286 | 292 | PF00069 | 0.636 |
MOD_CK2_1 | 79 | 85 | PF00069 | 0.504 |
MOD_Cter_Amidation | 231 | 234 | PF01082 | 0.412 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.676 |
MOD_GlcNHglycan | 289 | 292 | PF01048 | 0.745 |
MOD_GlcNHglycan | 97 | 100 | PF01048 | 0.653 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.598 |
MOD_GSK3_1 | 166 | 173 | PF00069 | 0.385 |
MOD_GSK3_1 | 220 | 227 | PF00069 | 0.319 |
MOD_GSK3_1 | 287 | 294 | PF00069 | 0.731 |
MOD_GSK3_1 | 95 | 102 | PF00069 | 0.411 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.717 |
MOD_NEK2_1 | 174 | 179 | PF00069 | 0.386 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.528 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.524 |
MOD_NEK2_1 | 95 | 100 | PF00069 | 0.550 |
MOD_PIKK_1 | 1 | 7 | PF00454 | 0.667 |
MOD_PIKK_1 | 114 | 120 | PF00454 | 0.540 |
MOD_PIKK_1 | 144 | 150 | PF00454 | 0.540 |
MOD_PIKK_1 | 184 | 190 | PF00454 | 0.542 |
MOD_PKA_1 | 233 | 239 | PF00069 | 0.458 |
MOD_PKA_2 | 224 | 230 | PF00069 | 0.396 |
MOD_PKA_2 | 233 | 239 | PF00069 | 0.464 |
MOD_Plk_1 | 166 | 172 | PF00069 | 0.372 |
MOD_Plk_1 | 54 | 60 | PF00069 | 0.530 |
MOD_Plk_4 | 14 | 20 | PF00069 | 0.452 |
MOD_Plk_4 | 55 | 61 | PF00069 | 0.469 |
MOD_ProDKin_1 | 217 | 223 | PF00069 | 0.477 |
MOD_SUMO_for_1 | 83 | 86 | PF00179 | 0.414 |
MOD_SUMO_rev_2 | 72 | 77 | PF00179 | 0.392 |
TRG_ENDOCYTIC_2 | 130 | 133 | PF00928 | 0.364 |
TRG_ENDOCYTIC_2 | 80 | 83 | PF00928 | 0.406 |
TRG_ER_diArg_1 | 19 | 22 | PF00400 | 0.556 |
TRG_ER_diArg_1 | 233 | 235 | PF00400 | 0.454 |
TRG_NES_CRM1_1 | 122 | 134 | PF08389 | 0.383 |
TRG_NLS_MonoCore_2 | 305 | 310 | PF00514 | 0.592 |
TRG_NLS_MonoExtC_3 | 306 | 311 | PF00514 | 0.623 |
TRG_NLS_MonoExtN_4 | 303 | 310 | PF00514 | 0.626 |
TRG_Pf-PMV_PEXEL_1 | 235 | 239 | PF00026 | 0.519 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IKD0 | Leptomonas seymouri | 74% | 85% |
A0A0S4JRX9 | Bodo saltans | 48% | 100% |
A0A1X0NKP4 | Trypanosomatidae | 60% | 100% |
A0A3R7KF49 | Trypanosoma rangeli | 59% | 92% |
A0A3S7WPM5 | Leishmania donovani | 83% | 99% |
A4HSZ8 | Leishmania infantum | 83% | 91% |
C9ZTN1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 63% | 100% |
E9AKY5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 94% |
Q4QIX0 | Leishmania major | 82% | 100% |
V5BXY4 | Trypanosoma cruzi | 59% | 99% |